These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28781099)

  • 1. Adverse events of prophylactic anti-influenza agents in medical staffs.
    Kato H; Hagihara M; Kato Y; Kurumiya A; Takahashi T; Sakata M; Nishiyama N; Asai N; Koizumi Y; Furui T; Yamagishi Y; Mikamo H
    J Infect Chemother; 2017 Oct; 23(10):683-686. PubMed ID: 28781099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oseltamivir, zanamivir and amantadine in the prevention of influenza: a systematic review.
    Jackson RJ; Cooper KL; Tappenden P; Rees A; Simpson EL; Read RC; Nicholson KG
    J Infect; 2011 Jan; 62(1):14-25. PubMed ID: 20950645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy outcome following maternal use of zanamivir or oseltamivir during the 2009 influenza A/H1N1 pandemic: a national prospective surveillance study.
    Dunstan HJ; Mill AC; Stephens S; Yates LM; Thomas SH
    BJOG; 2014 Jun; 121(7):901-6. PubMed ID: 24602087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oseltamivir and inhaled zanamivir as influenza prophylaxis in Thai health workers: a randomized, double-blind, placebo-controlled safety trial over 16 weeks.
    Anekthananon T; Pukrittayakamee S; Ratanasuwan W; Jittamala P; Werarak P; Charunwatthana P; Suwanagool S; Lawpoolsri S; Stepniewska K; Sapchookul P; Puthavathana P; Fukuda C; Lindegardh N; Tarning J; White NJ; Day N; Taylor WR
    J Antimicrob Chemother; 2013 Mar; 68(3):697-707. PubMed ID: 23143901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-viral drugs in flu: not that good?
    Arch Dis Child; 2014 Aug; 99(8):766. PubMed ID: 24914094
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of efficacy and safety of oseltamivir and zanamivir in pandemic influenza treatment.
    Tuna N; Karabay O; Yahyaoğlu M
    Indian J Pharmacol; 2012; 44(6):780-3. PubMed ID: 23248411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postexposure prophylaxis for influenza in pediatric wards oseltamivir or zanamivir after rapid antigen detection.
    Shinjoh M; Takano Y; Takahashi T; Hasegawa N; Iwata S; Sugaya N
    Pediatr Infect Dis J; 2012 Nov; 31(11):1119-23. PubMed ID: 22634596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized double-blind controlled study of laninamivir compared with oseltamivir for the treatment of influenza in patients with chronic respiratory diseases.
    Watanabe A
    J Infect Chemother; 2013 Feb; 19(1):89-97. PubMed ID: 22907567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control study.
    Vu D; Peck AJ; Nichols WG; Varley C; Englund JA; Corey L; Boeckh M
    Clin Infect Dis; 2007 Jul; 45(2):187-93. PubMed ID: 17578777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oseltamivir: new indication. Prevention of influenza in at-risk children: vaccination is best.
    Prescrire Int; 2007 Feb; 16(87):9-11. PubMed ID: 17323516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with intravenous zanamivir under an Emergency IND program in the United States (2011-2014).
    Chan-Tack KM; Kim C; Moruf A; Birnkrant DB
    Antivir Ther; 2015; 20(5):561-4. PubMed ID: 25667992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment.
    Smith JR; Sacks S
    Int J Clin Pract; 2009 Apr; 63(4):596-605. PubMed ID: 19335705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with clinical and virological response in patients treated with oseltamivir or zanamivir for influenza A during the 2008-2009 winter.
    Blanchon T; Mentré F; Charlois-Ou C; Dornic Q; Mosnier A; Bouscambert M; Carrat F; Duval X; Enouf V; Leport C;
    Clin Microbiol Infect; 2013 Feb; 19(2):196-203. PubMed ID: 22264308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influenza A, pregnancy and neuraminidase inhibitors].
    Montané E; Lecumberri J; Pedro-Botet ML
    Med Clin (Barc); 2011 May; 136(15):688-93. PubMed ID: 20416906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prophylactic Effect of Anti-influenza Agents for an Influenza Outbreak in a University Hospital.
    Hagihara M; Kato Y; Kurumiya A; Takahashi T; Sakata M; Kato H; Sakanashi D; Yamada A; Suematsu H; Hirai J; Nishiyama N; Koizumi Y; Yamagishi Y; Mikamo H
    Intern Med; 2018; 57(4):497-501. PubMed ID: 29445061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of infants exposed to oseltamivir or zanamivir in utero during pandemic (H1N1) 2009.
    Saito S; Minakami H; Nakai A; Unno N; Kubo T; Yoshimura Y
    Am J Obstet Gynecol; 2013 Aug; 209(2):130.e1-9. PubMed ID: 23583838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
    Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
    Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral drugs for influenza.
    Med Lett Drugs Ther; 2008 Dec 15-29; 50(1301-1302):98-9, 104; quiz p following 104. PubMed ID: 19078865
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.
    Sugaya N; Tamura D; Yamazaki M; Ichikawa M; Kawakami C; Kawaoka Y; Mitamura K
    Clin Infect Dis; 2008 Aug; 47(3):339-45. PubMed ID: 18582202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.